Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Prostatic Neoplasms 1 Neoplasm Metastasis 1 Endometrial Neoplasms 1

Interventions

Gemcitabine 74 Paclitaxel 60 Capecitabine 60 Fluorouracil 58 Oxaliplatin 57 Docetaxel 51 Bevacizumab 51 Leucovorin 48 Nivolumab 41 Irinotecan 40 Cisplatin 40 Carboplatin 37 Cetuximab 34 Radiosurgery 33 pembrolizumab 32 Trastuzumab 30 Radiotherapy 27 Everolimus 24 Sorafenib 23 Albumin-Bound Paclitaxel 21 Pemetrexed 20 Doxorubicin 20 Ipilimumab 19 Cyclophosphamide 19 Panitumumab 18 Zoledronic Acid 17 Lapatinib 17 Erlotinib Hydrochloride 17 Prednisone 16 pazopanib 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasm Metastasis × irosustat × Clear all

NCT01785992 2015-03-24

IRIS

Imperial College London

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡